Stock Valuations | Potential rise of up to 471.43%! Canaccord Genuity raised its target price for GUTS stock by $8, while maintaining its buy recommendation.
Sahm Platform 19/11 07:20
BTIG Maintains Buy on NeoGenomics, Lowers Price Target to $21
NeoGenomics, Inc. +2.93%
NeoGenomics, Inc. NEO | 0.00 |
BTIG analyst Mark Massaro maintains NeoGenomics (NASDAQ:
NEO) with a Buy and lowers the price target from $25 to $21.
Recommend
NIQ Global Intelligence (NYSE:NIQ): Assessing Valuation After Annual Results Show Revenue Growth but Profits Turn Negative
Simply Wall St 22/11 17:25A Look at Papa John's (PZZA) Valuation Following Major Executive Leadership Changes
Simply Wall St 22/11 18:15Debt Refinancing Move Could Be a Game Changer for Piedmont Realty Trust (PDM)
Simply Wall St 22/11 20:24Newegg (NEGG) Valuation in Focus as SHEIN Partnership Expands Reach to Fashion-Forward Tech Shoppers
Simply Wall St 23/11 01:20Will Fed Rate Cut Hopes Alter Bank of Hawaii’s (BOH) Outlook and Lending Risk?
Simply Wall St 23/11 02:21How Williams-Sonoma's Strong Q3 Results and New Buyback Plan May Impact WSM Investors
Simply Wall St 23/11 02:20Breakthrough And Pullback | 6 Stocks Deserve Close Attention: MEDP, INSM And More
Insights Today 03:39
